This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2002 Feb 16;324(7334):410-4.

doi: 10.1136/bmj.324.7334.410.

Breast cancer

Monica Morrow¹, William Gradishar

Affiliations

PMID: 11850376
PMCID: PMC1122337
DOI: 10.1136/bmj.324.7334.410

Review

Breast cancer

Monica Morrow et al. BMJ. 2002.

. 2002 Feb 16;324(7334):410-4.

doi: 10.1136/bmj.324.7334.410.

Authors

Monica Morrow¹, William Gradishar

Affiliation

¹ Department of Surgery, Northwestern University, Chicago, IL 60611, USA. mmorrow@nmh.org

PMID: 11850376
PMCID: PMC1122337
DOI: 10.1136/bmj.324.7334.410

No abstract available

PubMed Disclaimer

Figures

Figure
Sequence of treatment for postmenopausal women with hormone receptor positive, metastatic breast cancer. Antioestrogens are tamoxifen or torimefene. Non-steroidal aromatase inhibitors are anastrozole and letrozole. When fulvesterant is available for routine clinical use, it will also be a second line treatment

See this image and copyright information in PMC

Similar articles

Clinical management of BRCA1 and BRCA2 mutation carriers.
Domchek SM, Armstrong K, Weber BL. Domchek SM, et al. Nat Clin Pract Oncol. 2006 Jan;3(1):2-3. doi: 10.1038/ncponc0384. Nat Clin Pract Oncol. 2006. PMID: 16407858 No abstract available.
JAMA patient page. BRCA genes and breast cancer.
Pluta RM, Golub RM. Pluta RM, et al. JAMA. 2011 Jun 1;305(21):2244. doi: 10.1001/jama.305.21.2244. JAMA. 2011. PMID: 21632489 No abstract available.
Hereditary premenopausal breast cancer.
Strobel ES, Fritschka E. Strobel ES, et al. Onkologie. 2002 Feb;25(1):24-7. doi: 10.1159/000055198. Onkologie. 2002. PMID: 11893879 Review.
Surgical treatment of breast cancer in young women.
Piñero Madrona A. Piñero Madrona A. Breast Cancer Res Treat. 2010 Sep;123 Suppl 1:21-4. doi: 10.1007/s10549-010-1038-1. Epub 2010 Aug 14. Breast Cancer Res Treat. 2010. PMID: 20711670 No abstract available.
Radiotherapy for breast cancer in BRCA1/BRCA2 carriers: clinical issues and management dilemmas.
Pierce L. Pierce L. Semin Radiat Oncol. 2002 Oct;12(4):352-61. doi: 10.1053/srao.2002.35254. Semin Radiat Oncol. 2002. PMID: 12382193 Review.

See all similar articles

Cited by

Female white-collar workers remain at higher risk of breast cancer after adjustments for individual risk factors related to reproduction and lifestyle.
Kullberg C, Selander J, Albin M, Borgquist S, Manjer J, Gustavsson P. Kullberg C, et al. Occup Environ Med. 2017 Sep;74(9):652-658. doi: 10.1136/oemed-2016-104043. Epub 2017 Apr 29. Occup Environ Med. 2017. PMID: 28456763 Free PMC article.
Study on association between shear wave elastography parameters and clinicopathological characteristics in breast cancer: A protocol for systematic review.
Xue HH, Wang YY. Xue HH, et al. Medicine (Baltimore). 2020 Nov 20;99(47):e23082. doi: 10.1097/MD.0000000000023082. Medicine (Baltimore). 2020. PMID: 33217808 Free PMC article.
Fulvestrant: a review of its use in hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
McKeage K, Curran MP, Plosker GL. McKeage K, et al. Drugs. 2004;64(6):633-48. doi: 10.2165/00003495-200464060-00009. Drugs. 2004. PMID: 15018596 Review.
Antimetastatic gene expression profiles mediated by retinoic acid receptor beta 2 in MDA-MB-435 breast cancer cells.
Wallden B, Emond M, Swift ME, Disis ML, Swisshelm K. Wallden B, et al. BMC Cancer. 2005 Oct 28;5:140. doi: 10.1186/1471-2407-5-140. BMC Cancer. 2005. PMID: 16255778 Free PMC article.
Investigating the risk of breast cancer among women exposed to chemicals: a nested case-control study using improved exposure estimates.
Videnros C, Selander J, Wiebert P, Albin M, Plato N, Borgquist S, Manjer J, Gustavsson P. Videnros C, et al. Int Arch Occup Environ Health. 2020 Feb;93(2):261-269. doi: 10.1007/s00420-019-01479-4. Epub 2019 Oct 24. Int Arch Occup Environ Health. 2020. PMID: 31650237 Free PMC article.

References

1. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet. 1998;62:676–689. - PMC - PubMed
1. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 1977;336:1401–1408. - PubMed
1. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for the prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst. 1999;90:1371–1388. - PubMed
1. King MC, Wieand S, Dalakishvili K, Lee M, Walsh T, Owens K, et al. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 or BRCA2. National surgical adjuvant breast and bowel (NSABP) breast cancer prevention trial. JAMA. 2001;286:2251–2258. - PubMed
1. Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL, et al. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Lancet. 2000;356:1876–1881. - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information